Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Drug-Induced Adverse Reactions”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Food Allergy OceanSide Publications, Inc · United States Publishes on: Drug-Induced Adverse Reactions (24%) | 100% | 51.7 | #18,315 | 85 | 98% | Not recorded | |
| 2 | The Journal of Allergy and Clinical Immunology In Practice Elsevier BV · The Netherlands Publishes on: Drug-Induced Adverse Reactions (15%) | 63% | 81.0 | #1,823 | 3,468 | 53% | Not recorded | |
| 3 | Current Drug Safety Bentham Science Publishers · The Netherlands Publishes on: Drug-Induced Adverse Reactions (16%) | 67% | 63.2 | #10,908 | 341 | 9% | Not recorded | |
| 4 | Indian Journal of Drugs in Dermatology Medknow · India Publishes on: Drug-Induced Adverse Reactions (18%) | 76% | 42.0 | #26,307 | 78 | 100% | Not recorded | |
| 5 | Journal of Pharmacology and Pharmacotherapeutics SAGE Publishing · India Publishes on: Drug-Induced Adverse Reactions (13%) | 54% | 69.7 | #6,947 | 245 | 93% | Not recorded | |
| 6 | Asthma Allergy Immunology Türkiye Publishes on: Drug-Induced Adverse Reactions (16%) | 67% | 40.4 | #27,924 | 188 | 100% | Not recorded | |
| 7 | Journal of Investigational Allergology and Clinical Immunology ESMON Publicidad · Spain Publishes on: Drug-Induced Adverse Reactions (13%) | 54% | 62.7 | #11,221 | 477 | 100% | Not recorded | |
| 8 | Internal Medicine Journal Wiley · Australia Publishes on: Drug-Induced Adverse Reactions (12%) | 50% | 70.1 | #6,738 | 2,360 | 55% | Not recorded | |
| 9 | Expert Opinion on Drug Safety Taylor & Francis · United Kingdom Publishes on: Drug-Induced Adverse Reactions (10%) | 43% | 77.3 | #3,155 | 969 | 22% | Not recorded | |
| 10 | Drug Safety Adis, Springer Healthcare · New Zealand Publishes on: Drug-Induced Adverse Reactions (9%) | 38% | 83.0 | #1,249 | 605 | 71% | Not recorded | |
| 11 | Allergies Multidisciplinary Digital Publishing Institute · Switzerland · DOAJ Publishes on: Drug-Induced Adverse Reactions (11%) | 49% | 46.3 | #22,426 | 109 | 100% | 1,000 CHF | |
| 12 | Annals of Allergy Asthma & Immunology Elsevier BV · United States Publishes on: Drug-Induced Adverse Reactions (8%) | 34% | 71.6 | #5,872 | 4,745 | 29% | Not recorded | |
| 13 | European Annals of Allergy and Clinical Immunology Italy Publishes on: Drug-Induced Adverse Reactions (10%) | 42% | 56.0 | #15,452 | 236 | 96% | Not recorded | |
| 14 | Current Opinion in Allergy and Clinical Immunology Lippincott Williams & Wilkins · United States Publishes on: Drug-Induced Adverse Reactions (8%) | 32% | 73.5 | #4,891 | 387 | 24% | Not recorded | |
| 15 | Reactions Weekly Adis, Springer Healthcare · New Zealand Publishes on: Drug-Induced Adverse Reactions (11%) | 47% | 44.8 | #23,712 | 101,602 | 4% | Not recorded | |
| 16 | Asia Pacific Allergy Lippincott Williams & Wilkins · South Korea Publishes on: Drug-Induced Adverse Reactions (9%) | 38% | 59.3 | #13,366 | 251 | 100% | Not recorded | |
| 17 | Journal of Allergy and Clinical Immunology Global Elsevier BV · United States · DOAJ Publishes on: Drug-Induced Adverse Reactions (9%) | 36% | 61.8 | #11,754 | 617 | 100% | US$2,000 | |
| 18 | Clinical and Translational Allergy Springer Science+Business Media · United States · DOAJ Publishes on: Drug-Induced Adverse Reactions (7%) | 30% | 72.7 | #5,316 | 582 | 100% | US$3,690 | |
| 19 | Current Treatment Options in Allergy Springer Science+Business Media · Switzerland Publishes on: Drug-Induced Adverse Reactions (9%) | 38% | 55.1 | #16,066 | 132 | 37% | Not recorded | |
| 20 | Allergy Asthma and Clinical Immunology BioMed Central · Canada · DOAJ Publishes on: Drug-Induced Adverse Reactions (7%) | 28% | 72.7 | #5,304 | 498 | 100% | 2,690 EUR | |
| 21 | RCSB Protein Data Bank Poland Publishes on: Drug-Induced Adverse Reactions (12%) | 51% | 29.5 | #40,995 | 163 | 1% | Not recorded | |
| 22 | Alergologia Romania Publishes on: Drug-Induced Adverse Reactions (12%) | 52% | 28.2 | #42,644 | 133 | 83% | Not recorded | |
| 23 | World Allergy Organization Journal Elsevier BV · United Kingdom · DOAJ Publishes on: Drug-Induced Adverse Reactions (6%) | 26% | 74.4 | #4,422 | 631 | 100% | US$2,840 | |
| 24 | Contact Dermatitis Wiley · United Kingdom Publishes on: Drug-Induced Adverse Reactions (6%) | 26% | 73.7 | #4,752 | 1,228 | 54% | Not recorded | |
| 25 | Revista Portuguesa de Imunoalergologia Portugal · DOAJ Publishes on: Drug-Induced Adverse Reactions (12%) | 52% | 23.2 | #49,039 | 150 | 100% | Not recorded | |
| 26 | Clinical & Experimental Allergy Wiley · United Kingdom Publishes on: Drug-Induced Adverse Reactions (5%) | 23% | 76.4 | #3,539 | 1,072 | 69% | Not recorded | |
| 27 | Allergologia et Immunopathologia Elsevier BV · Spain Publishes on: Drug-Induced Adverse Reactions (7%) | 28% | 66.2 | #9,081 | 646 | 100% | Not recorded | |
| 28 | Revista Alergia México Colegio Mexicano de Inmunología Clínica y Alergia, A.C. · Mexico · DOAJ Publishes on: Drug-Induced Adverse Reactions (9%) | 37% | 46.3 | #22,380 | 340 | 100% | US$300 | |
| 29 | Arquivos de Asmas Alergia e Imunologia Editora Cubo · Brazil Publishes on: Drug-Induced Adverse Reactions (10%) | 44% | 31.8 | #38,138 | 416 | 80% | Not recorded | |
| 30 | Rivista di immunologia ed allergologia pediatrica. Pacini Editore · Italy Publishes on: Drug-Induced Adverse Reactions (11%) | 46% | 26.9 | #44,364 | 69 | 100% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.